Oncologic Efficacy of Laparoscopic RPLND in Treatment of Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer

Urology

Volumn 70, Issue 6, 2007, Pages 1168-1172

  Nielsen, Matthew E ^a   Lima, Guilherme ^a   Schaeffer, Edward M ^a   Porter, James ^b   Cadeddu, Jeffrey A ^c   Tuerk, Ingolf ^d   Kavoussi, Louis R ^e  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e Northwell Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; CLINICAL EXAMINATION; FOLLOW UP; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TESTIS CANCER;

HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; ORCHIECTOMY; RETROPERITONEAL SPACE; TESTICULAR NEOPLASMS;

EID: 37349125538     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.08.041     Document Type: Article

References (25)

1. Read G., Stenning S.P., Cullen M.H., et al., Medical Research Council Testicular Tumors Working Party. Medical Research Council prospective study of surveillance for stage I testicular teratoma. J Clin Oncol 10 (1992) 1762-1768
2. Nicolai N., and Pizzocaro G. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J Urol 154 (1995) 1045-1049
3. Sogani P.C., Perrotti M., Herr H.W., et al. Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol 159 (1998) 855-858
4. Donohue J.P., Thornhill J.A., Foster R.S., et al. Stage I nonseminomatous germ-cell testicular cancer-management options and risk-benefit considerations. World J Urol 12 (1994) 170-177
5. Oliver R.T., Raja M.A., Ong J., et al. Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients. J Urol 148 (1992) 1453-1456
6. Bohlen D., Borner M., Sonntag R.W., et al. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. J Urol 161 (1999) 1148-1152
7. Leisinger H.J., and Donohue J.P. The role of retroperitoneal surgery in testis cancer. Crit Rev Oncol Hematol 44 (2002) 71-80
8. Donohue J.P., Thornhill J.A., Foster R.S., et al. Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer: review of the Indiana University experience 1965-1989. Br J Urol 71 (1993) 326-335
9. Janetschek G., Hobisch A., Holtl L., et al. Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: laparoscopy versus open surgery and impact of learning curve. J Urol 156 (1996) 89-94
10. Nelson J.B., Chen R.N., Bishoff J.T., et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors. Urology 54 (1999) 1064-1067
11. Allaf M.E., Bhayani S.B., Link R.E., et al. Laparoscopic retroperitoneal lymph node dissection: duplication of open technique. Urology 65 (2005) 575-577
12. Carver B.S., and Sheinfeld J. Therapeutic efficacy of laparoscopic RPLND: unproved and untested. Am J Urol Rev 2 (2004) 427
13. Sheinfeld J. Open vs. Laparoscopic RPLND: the risk of performing RPLND without therapeutic intent. AUA News 13 (2005) 11-13
14. Donohue J.P., Thornhill J.A., Foster R.S., et al. Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation. J Urol 149 (1993) 237-243
15. Weissbach L., Boedefeld E.A., Horstmann-Dubral B., and Testicular Tumor Study Group. Surgical treatment of stage-I non-seminomatous germ cell testis tumor: final results of a prospective multicenter trial 1982-1987. Eur Urol 17 (1990) 97-106
16. Rabbani F., Goldenberg S.L., Gleave M.E., et al. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient?. Br J Urol 81 (1998) 295-300
17. Sherlag A.P., O'Brien III D.P., and Graham Jr. S.D. Use of limited retroperitoneal lymphadenectomy in nonseminomatous germ cell tumors. Urology 33 (1989) 355-357
18. Peschel R., Gettman M.T., Neururer R., et al. Laparoscopic retroperitoneal lymph node dissection: description of the nerve-sparing technique. Urology 60 (2002) 339-343
19. McKiernan J.M., Motzer R.J., Bajorin D.F., et al. Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome. Urology 62 (2003) 732-736
20. Baniel J., Foster R.S., Gonin R., et al. Late relapse of testicular cancer. J Clin Oncol 13 (1995) 1170-1176
21. Sheinfeld J. Late relapse of testicular cancer. AUA News 6 (2001) 12
22. Rabbani F., Sheinfeld J., Farivar-Mohseni H., et al. Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol 19 (2001) 2020-2025
23. Hartlapp J.H., Weissbach L., and Bussar-Maatz R. Adjuvant chemotherapy in nonseminomatous testicular tumour stage II. Int J Androl 10 (1987) 277-284
24. Richie J.P., and Kantoff P.W. Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?. J Clin Oncol 9 (1991) 1393-1396
25. Dieckmann K.P., Albers P., Classen J., et al. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. J Urol 173 (2005) 824-829